Evidence map›Paper›PMID 28302395›Full record

ArticleSchizophrenia research2017

Social cognition psychometric evaluation (SCOPE) in people with early psychosis: A preliminary study.

Kelsey A Ludwig, Amy E Pinkham, Philip D Harvey, Skylar Kelsven, David L Penn

Open access · greenAbstract readEvaluation Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Schizophrenia research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 4 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 4 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses.European psychiatry : the journal of the Association of European Psychiatrists · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Kelsey A LudwigDepartment of Psychology and Neuroscience, University of North Carolina, Chapel Hill, NC, United States. Electronic address: Kelsey_Ludwig@med.unc.edu.
Amy E PinkhamSchool of Behavioral and Brain Sciences, The University of Texas at Dallas, Richardson, TX, United States; Department of Psychiatry, University of Texas Southwestern Medical School, Dallas, TX, United States.
Philip D HarveyDepartment of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, United States; Research Service, Miami VA Healthcare System, United States.
Skylar KelsvenDepartment of Psychology, San Diego State University, The University of California at San Diego, San Diego, CA, United States.
David L PennDepartment of Psychology and Neuroscience, University of North Carolina, Chapel Hill, NC, United States; School of Psychology, Australian Catholic University, Melbourne, VIC, Australia.
University of North Carolina at Chapel Hill · USMiami VA Healthcare System · USSan Diego State University · USThe University of Texas Southwestern Medical Center · US

Funding

Social Cognition Psychometric EvaluationR01MH093432 · NIMH · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI HARVEY, PHILIP D., PENN, DAVID LEWIS · 2012 to 2016
$3.2M
NIMH NIH HHS R01 MH093432
6 · The paper itself

Abstract

Social cognition is an important outcome in schizophrenia research. Unfortunately, there has been a lack of consensus regarding which measures of social cognition best capture this domain of functioning. The Social Cognition Psychometric Evaluation (SCOPE) study was developed to address the need for a battery of measures that have sound psychometric properties and can be implemented in clinical trials for individuals with chronic schizophrenia. The current study expands upon the SCOPE study by examining the psychometric properties of the eight candidate measures administered to individuals early in the course of psychosis. Thirty-eight stable outpatients with first episode psychosis and thirty-nine healthy controls completed the battery at baseline and one-month follow-up assessments. The SCOPE battery was evaluated on a collection of psychometric properties, including: (1) Reliability - including test-retest and internal consistency, (2) Between group differences, (3) Utility as a repeated measure, (4) Relationship to social and occupational functioning, (5) Incremental validity - variance in functioning beyond neurocognition, and (6) Feasibility - including practicality of administration and tolerability. Social cognition accounted for substantially more variance in functional outcome than neurocognition. Only one measure, the Hinting task, displayed adequate psychometric properties to be recommended for use in clinical research with first episode psychosis. The remaining candidate measures would require modifications before implementation or cannot be recommended for use in clinical research with first episode psychosis.

Indexed as

CognitionPsychiatric Status Rating ScalesSocial PerceptionAdultFemaleHumansMalePreliminary DataPsychometricsPsychotic DisordersRegression AnalysisReproducibility of ResultsSchizophreniaSchizophrenic PsychologyYoung AdultFirst episode psychosisMeasurementPsychometric evaluationSchizophreniaSocial cognition

Identifiers

PMID28302395
PMCPMC5735418
OpenAlexW2596697771

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.